4//SEC Filing
Gallagher Brian M. Jr. 4
Accession 0000899243-18-019455
CIK 0001693415other
Filed
Jul 4, 8:00 PM ET
Accepted
Jul 5, 4:30 PM ET
Size
18.2 KB
Accession
0000899243-18-019455
Insider Transaction Report
Form 4
Gallagher Brian M. Jr.
Director
Transactions
- Conversion
Common Stock
2018-07-02+1,300,116→ 2,974,132 total(indirect: See Footnote) - Conversion
Series B Preferred Stock
2018-07-02−7,222,797→ 0 total(indirect: See Footnote)→ Common Stock (1,300,116 underlying) - Conversion
Common Stock
2018-07-02+1,674,016→ 1,674,016 total(indirect: See Footnote) - Conversion
Common Stock
2018-07-02+454,550→ 3,428,682 total(indirect: See Footnote) - Purchase
Common Stock
2018-07-02$13.00/sh+269,230$3,499,990→ 3,697,912 total(indirect: See Footnote) - Conversion
Series C Preferred Stock
2018-07-02−2,525,253→ 0 total(indirect: See Footnote)→ Common Stock (454,550 underlying) - Conversion
Series A Preferred Stock
2018-07-02−9,300,000→ 0 total(indirect: See Footnote)→ Common Stock (1,674,016 underlying)
Footnotes (3)
- [F1]Reflects shares of the Issuer's Common Stock that were purchased in connection with the Issuer's initial public offering.
- [F2]The Series A, Series B and Series C Preferred Stock were converted into Common Stock on a 5.5555-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A, Series B, and Series C Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date.
- [F3]S.R. One, Limited, an indirect,wholly-owned subsidiary of GlaxoSmithKline plc, is the record holder of these shares reported herein. Brian M. Gallagher, Jr. is a Partner and Vice President at S.R. One, Limited and an employee of GlaxoSmithKline LLC, an indirect, wholly-owned subsidiary of GlaxoSmithKline plc. Mr. Gallagher disclaims beneficial ownership of all shares held by S.R. One, Limited and this report shall not be deemed an admission of beneficial ownership of such shares for the purpose of Section 16 or for any other purpose except to the extent of his pecuniary interest therein.
Documents
Issuer
Translate Bio, Inc.
CIK 0001693415
Entity typeother
Related Parties
1- filerCIK 0001709976
Filing Metadata
- Form type
- 4
- Filed
- Jul 4, 8:00 PM ET
- Accepted
- Jul 5, 4:30 PM ET
- Size
- 18.2 KB